Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66901 - 66925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	AGRP	181	upregulated	rosiglitazone results in increased expression of AGRP mRNA	16q22.1	A20427
Rosiglitazone	Approved Investigational	AGXT2	64902	downregulated	rosiglitazone results in decreased expression of AGXT2 mRNA	5p13.2	A22609
Rosiglitazone	Approved Investigational	AJAP1	55966	upregulated	rosiglitazone results in increased expression of AJAP1 mRNA	1p36.32	A10216
Rosiglitazone	Approved Investigational	ALAS1	211	upregulated	rosiglitazone results in increased expression of ALAS1 mRNA	3p21.2	A22609
Rosiglitazone	Approved Investigational	ALDH1A2	8854	upregulated	rosiglitazone results in increased expression of ALDH1A2 mRNA	15q21.3	A10216
Rosiglitazone	Approved Investigational	ALDH3A2	224	upregulated	rosiglitazone results in increased expression of ALDH3A2 mRNA	17p11.2	A22609
Rosiglitazone	Approved Investigational	ALDH8A1	64577	downregulated	rosiglitazone results in decreased expression of ALDH8A1 mRNA	6q23.3	A22609
Rosiglitazone	Approved Investigational	ALDOB	229	downregulated	rosiglitazone results in decreased expression of ALDOB mRNA	9q31.1	A22609
Rosiglitazone	Approved Investigational	ALPL	249	downregulated	rosiglitazone results in decreased expression of ALPL mRNA	1p36.12	A22609
Rosiglitazone	Approved Investigational	ANAPC10	10393	downregulated	rosiglitazone results in decreased expression of ANAPC10 mRNA	4q31.21	A24100
Rosiglitazone	Approved Investigational	ANGPTL4	51129	upregulated	rosiglitazone results in increased expression of ANGPTL4 mRNA	19p13.2	A22609 A20427
Rosiglitazone	Approved Investigational	ANXA10	11199	downregulated	rosiglitazone results in decreased expression of ANXA10 mRNA	4q32.3	A22609
Rosiglitazone	Approved Investigational	APAF1	317	downregulated	rosiglitazone results in decreased expression of APAF1 mRNA	12q23.1	A24100
Rosiglitazone	Approved Investigational	APLP2	334	upregulated	rosiglitazone results in increased expression of APLP2 mRNA	11q24.3	A10216
Rosiglitazone	Approved Investigational	APOA4	337	downregulated	rosiglitazone results in decreased expression of APOA4 mRNA	11q23.3	A22609
Rosiglitazone	Approved Investigational	APOE	348	upregulated	rosiglitazone results in increased expression of APOE mRNA	19q13.32	A20966
Rosiglitazone	Approved Investigational	ARFGEF2	10564	upregulated	rosiglitazone results in increased expression of ARFGEF2 mRNA	20q13.13	A20427
Rosiglitazone	Approved Investigational	ARG1	383	downregulated	rosiglitazone results in decreased expression of ARG1 mRNA	6q23.2	A22609
Rosiglitazone	Approved Investigational	ARHGEF10	9639	downregulated	rosiglitazone results in decreased expression of ARHGEF10 mRNA	8p23.3	A20427
Rosiglitazone	Approved Investigational	ASGR2	433	downregulated	rosiglitazone results in decreased expression of ASGR2 mRNA	17p13.1	A22609
Rosiglitazone	Approved Investigational	ASPDH	554235	downregulated	rosiglitazone results in decreased expression of ASPDH mRNA	19q13.33	A22609
Rosiglitazone	Approved Investigational	ATF3	467	upregulated	rosiglitazone results in increased expression of ATF3 mRNA	1q32.3	A20427
Rosiglitazone	Approved Investigational	ATP2A2	488	upregulated	rosiglitazone results in increased expression of ATP2A2 mRNA	12q24.11	A24101 A24102 A22609
Rosiglitazone	Approved Investigational	ATP2B1	490	downregulated	rosiglitazone results in decreased expression of ATP2B1 mRNA	12q21.33	A10216
Rosiglitazone	Approved Investigational	ATP2B4	493	upregulated	rosiglitazone results in increased expression of ATP2B4 mRNA	1q32.1	A22609

Displaying entries 66901 - 66925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability